Literature DB >> 26463946

Src Family Kinases in Brain Edema After Acute Brain Injury.

DaZhi Liu1, Xiong Zhang2, BeiLei Hu2, Bradley P Ander3.   

Abstract

Brain edema, the first stage of intracranial hypertension, has been associated with poor prognosis and increased mortality after acute brain injury such as ischemic stroke, intracranial hemorrhage (ICH), and traumatic brain injury (TBI). Acute brain injury often initiates release of many molecules, including glutamate, adenosine, thrombin, oxyhemoglobin, cytokines, reactive oxygen species (ROS), damage-associated molecular pattern molecules (DAMPs), and others. Most of these molecules activate Src family kinases (SFKs), a family of proto-oncogenic non-receptor tyrosine kinases, resulting in blood-brain barrier (BBB) disruption and brain edema at the acute stage after brain injury. However, SFKs also contribute to BBB self-repair and brain edema resolution in the chronic stage that follows brain injury. In this review, we summarize possible pathways through which SFKs are implicated in both brain edema formation and its eventual resolution.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26463946      PMCID: PMC5100806          DOI: 10.1007/978-3-319-18497-5_33

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  100 in total

1.  Vascular niche for adult hippocampal neurogenesis.

Authors:  T D Palmer; A R Willhoite; F H Gage
Journal:  J Comp Neurol       Date:  2000-10-02       Impact factor: 3.215

2.  Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing.

Authors:  Christina I Herold; Vijaya Chadaram; Bercedis L Peterson; P Kelly Marcom; Judith Hopkins; Gretchen G Kimmick; Justin Favaro; Erika Hamilton; Renee A Welch; Sarah Bacus; Kimberly L Blackwell
Journal:  Clin Cancer Res       Date:  2011-08-02       Impact factor: 12.531

3.  Brain-specific src oncogene mRNA mapped in rat brain by in situ hybridization.

Authors:  C A Ross; G E Wright; M D Resh; R C Pearson; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Predictors of fatal brain edema in massive hemispheric ischemic stroke.

Authors:  S E Kasner; A M Demchuk; J Berrouschot; E Schmutzhard; L Harms; P Verro; J A Chalela; R Abbur; H McGrade; I Christou; D W Krieger
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

5.  KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.

Authors:  Muralidharan Anbalagan; Latonya Carrier; Seth Glodowski; David Hangauer; Bin Shan; Brian G Rowan
Journal:  Breast Cancer Res Treat       Date:  2011-04-21       Impact factor: 4.872

6.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

7.  SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage.

Authors:  Timothy D Ardizzone; Xinhua Zhan; Brad P Ander; Frank R Sharp
Journal:  Stroke       Date:  2007-03-29       Impact factor: 7.914

8.  Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils.

Authors:  J Liu; K Solway; R O Messing; F R Sharp
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

9.  Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood.

Authors:  Tomasz Dziedzic; Stanislaw Bartus; Aleksandra Klimkowicz; Maciej Motyl; Agnieszka Slowik; Andrzej Szczudlik
Journal:  Stroke       Date:  2002-09       Impact factor: 7.914

Review 10.  Interfering with disease: a progress report on siRNA-based therapeutics.

Authors:  Antonin de Fougerolles; Hans-Peter Vornlocher; John Maraganore; Judy Lieberman
Journal:  Nat Rev Drug Discov       Date:  2007-06       Impact factor: 84.694

View more
  7 in total

Review 1.  Src family kinases in chronic kidney disease.

Authors:  Jun Wang; Shougang Zhuang
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-14

2.  3-Hydroxy-3-Methylglutaric Acid Impairs Redox and Energy Homeostasis, Mitochondrial Dynamics, and Endoplasmic Reticulum-Mitochondria Crosstalk in Rat Brain.

Authors:  Mateus Struecker da Rosa; Nevton Teixeira da Rosa-Junior; Belisa Parmeggiani; Nícolas Manzke Glänzel; Leonardo de Moura Alvorcem; Rafael Teixeira Ribeiro; Mateus Grings; Moacir Wajner; Guilhian Leipnitz
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

Review 3.  Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases.

Authors:  Meghan C Gage; Thimmasettappa Thippeswamy
Journal:  CNS Drugs       Date:  2021-01-30       Impact factor: 5.749

Review 4.  Prospects of honey in fighting against COVID-19: pharmacological insights and therapeutic promises.

Authors:  Khandkar Shaharina Hossain; Md Golzar Hossain; Akhi Moni; Md Mahbubur Rahman; Umma Habiba Rahman; Mohaimanul Alam; Sushmita Kundu; Md Masudur Rahman; Md Abdul Hannan; Md Jamal Uddin
Journal:  Heliyon       Date:  2020-12-21

Review 5.  Microenvironmental Variations After Blood-Brain Barrier Breakdown in Traumatic Brain Injury.

Authors:  Yue Hu; Weiwei Tao
Journal:  Front Mol Neurosci       Date:  2021-11-26       Impact factor: 5.639

Review 6.  Fyn Kinase: A Potential Therapeutic Target in Acute Kidney Injury.

Authors:  Md Jamal Uddin; Debra Dorotea; Eun Seon Pak; Hunjoo Ha
Journal:  Biomol Ther (Seoul)       Date:  2020-05-01       Impact factor: 4.634

7.  Differential Impact of Severity and Duration of Status Epilepticus, Medical Countermeasures, and a Disease-Modifier, Saracatinib, on Brain Regions in the Rat Diisopropylfluorophosphate Model.

Authors:  Meghan Gage; Marson Putra; Crystal Gomez-Estrada; Madison Golden; Logan Wachter; Megan Gard; Thimmasettappa Thippeswamy
Journal:  Front Cell Neurosci       Date:  2021-10-15       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.